Subject	Predicate	Object
LLyETitk	a	Resource
		Answer
		Written answer
	answer has question	5u4lazDn
	answer has answering person	William James Quince
	answer text	<p>The voluntary scheme for branded medicines pricing and access (VPAS) includes strong commercial incentives to launch new products in the form of freedom of list pricing and exemptions from payments for innovative medicines containing a new active substance. At the mid-scheme review for the 2019 VPAS, the Department and NHS England concluded that the scheme had been effective in supporting patient access to innovative medicines.</p><p>The terms of the successor to VPAS are subject to ongoing confidential negotiations. Supporting patient access to innovative medicines will continue to be one of the scheme’s objectives, alongside ensuring the affordability of National Health Service spend on medicines and supporting the life sciences sector and the wider economy.</p>
	answer given date	2023-09-11
	answer has answering body	Department of Health and Social Care
	written answer has answering body	Department of Health and Social Care
Department of Health and Social Care	answering body has written answer	LLyETitk
Department of Health and Social Care	answering body has answer	LLyETitk
5u4lazDn	question has answer	LLyETitk
William James Quince	answering person has answer	LLyETitk